Primary cutaneous aspergillosis : An emerging infection among immunocompromised patientsWALSH, T. J.Clinical infectious diseases. 1998, Vol 27, Num 3, pp 453-457, issn 1058-4838Article

Site-specific pharmacology for the treatment of Alzheimer's diseaseWALSH, T. J.Experimental neurology (Print). 1993, Vol 124, Num 1, pp 43-46, issn 0014-4886Article

The etymology of Hispano-Romance Tomar 'to take'WALSH, T. J.Hispanic review. 2000, Vol 68, Num 3, pp 243-265, issn 0018-2176Article

Spanish Historical Linguistics : Advances in the 1980s in Contemporary Trends in Hispanic and Luso-Brazilian Linguistics : part 2WALSH, T. J.Hispania. 1990, Vol 73, Num 1, pp 177-200, issn 0018-2133Article

Immunotherapy of Cryptococcus infections : Modulating the immune system against fungal infections: where are we ?ANTACHOPOULOS, C; WALSH, T. J.Clinical microbiology and infection. 2012, Vol 18, Num 2, pp 126-133, issn 1198-743X, 8 p.Article

Evolving role of flucytosine in immunocompromised patients : new insights into safety, pharmacokinetics, and antifungal therapyFRANCIS, P; WALSH, T. J.Clinical infectious diseases. 1992, Vol 15, Num 6, pp 1003-1018Article

Diagnosis of invasive fungal infections in immunocompromised children : Invasive fungal infections in paediatric patientsDORNBUSCH, H. J; GROLL, A; WALSH, T. J et al.Clinical microbiology and infection. 2010, Vol 16, Num 9, pp 1328-1334, issn 1198-743X, 7 p.Article

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohortHIEMENZ, J. W; RAAD, I. I; RYAN, D. M et al.European journal of clinical microbiology & infectious diseases (Print). 2010, Vol 29, Num 11, pp 1387-1394, issn 0934-9723, 8 p.Article

Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin BSIMITSOPOULOU, M; ROILIDES, E; DOTIS, J et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1397-1403, issn 0066-4804, 7 p.Article

Infections due to emerging and uncommon medically important fungal pathogensWALSH, T. J; GROLL, A; HIEMENZ, J et al.Clinical microbiology and infection. Supplement. 2004, Vol 10, Num 1, pp 48-66, issn 1470-9465, 19 p.Article

Antifungal activity of splenic, liver and pulmonary macrophages against Candida albicans and effects of macrophage colony-stimulating factorROILIDES, E; LYMAN, C. A; SEIN, T et al.Medical mycology (Oxford. Print). 2000, Vol 38, Num 2, pp 161-168, issn 1369-3786Article

D-Cecropin B : Proteolytic resistance, lethality for pathogenic fungi and binding propertiesDE LUCCA, A. J; BLAND, J. M; VIGO, C. B et al.Medical mycology (Oxford. Print). 2000, Vol 38, Num 4, pp 301-308, issn 1369-3786Article

Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbitsWALSH, T. J; JACKSON, A. J; LEE, J. W et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 8, pp 2068-2076, issn 0066-4804Article

Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbitsPETRAITIENE, R; PETRAITIS, V; GROLL, A. H et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 9, pp 2148-2155, issn 0066-4804Article

Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbitsGROLL, A. H; SEIN, T; PETRAITIS, V et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 10, pp 2700-2705, issn 0066-4804Article

Septocingulate and septohippocampal cholinergic pathways : involvement in working/episodic memoryDOUGHERTY, K. D; TURCHIN, P. I; WALSH, T. J et al.Brain research. 1998, Vol 810, Num 1-2, pp 59-71, issn 0006-8993Article

New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes : implications for antifungal azole resistanceWALSH, T. J; KASAI, M; FRANCESCONI, A et al.Journal of medical and veterinary mycology. 1997, Vol 35, Num 2, pp 133-137, issn 0268-1218Article

Development of interpretive breakpoints for antifungal susceptibility testing : Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Author's replyREX, J. H; PFALLER, M. A; BARRY, A. L et al.Clinical infectious diseases. 1997, Vol 24, Num 2, pp 235-249, issn 1058-4838Article

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungiESPINEL-INGROFF, A; BARTLETT, M; ODDS, F. C et al.Journal of clinical microbiology (Print). 1997, Vol 35, Num 1, pp 139-143, issn 0095-1137Article

Antifungal agents : chemotherapeutic targets and immunologic strategiesGEORGOPAPADAKOU, N. H; WALSH, T. J.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 2, pp 279-291, issn 0066-4804Article

Lipid formulations of amphotericin B : Recent progress and future directionsHIEMENZ, J. W; WALSH, T. J.Clinical infectious diseases. 1996, Vol 22, pp S133-S144, issn 1058-4838, SUP2Conference Paper

A single intraseptal injection of nerve growth factor facilitates radial maze performance following damage to the medial septum in ratsJANIS, L. S; GLASIER, M. M; MARTIN, G et al.Brain research. 1995, Vol 679, Num 1, pp 99-109, issn 0006-8993Article

Anatomical specificity and time-dependence of chlordiazepoxide-induced spatial memory impairmentsSTACKMAN, R. W; WALSH, T. J.Behavioral neuroscience. 1995, Vol 109, Num 3, pp 436-445, issn 0735-7044Article

Distinct profile of working memory errors following acute or chronic disruption of the cholinergic septohippocampal pathwaySTACKMAN, R. W; WALSH, T. J.Neurobiology of learning and memory (Print). 1995, Vol 64, Num 3, pp 226-236, issn 1074-7427Article

Human mycoses : drugs and targets for emerging pathogensGEORGOPAPADAKOU, N. H; WALSH, T. J.Science (Washington, D.C.). 1994, Vol 264, Num 5157, pp 371-373, issn 0036-8075Article